Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

DACARBAZINE

DACARBAZINE

Standard Dose
200MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview DACARBAZINE is listed in Drugs@FDA under application 075940 (ANDA).

Marketing status: Discontinued Active ingredient DACARBAZINE Form and strength INJECTABLE;INJECTION - 200MG/VIAL Sponsor HOSPIRA Submission history Latest submission status date: 2001-10-18 00:00:00.

Structured Monograph

Clinical summary

Approval overview DACARBAZINE is listed in Drugs@FDA under application 075940 (ANDA). Marketing status: Discontinued Active ingredient DACARBAZINE Form and strength INJECTABLE;INJECTION - 200MG/VIAL Sponsor HOSPIRA Submission history Latest submission status date: 2001-10-18 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.